Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Rubius Therapeutics Inc. sell WatchMen

Start price
€9.60
26.12.21 / 0%
Target price
-
26.12.22
Performance (%)
-98.17%
End price
€0.18
27.12.22
Summary
This prediction ended on 27.12.22 with a price of €0.18. The SELL prediction by WatchMen for Rubius Therapeutics Inc. performed very well with a performance of -98.17%. This prediction was marked as speculative and is excluded from WatchMen's performance statistics.
Performance without dividends (%)
Name 1w 1m 1y
Rubius Therapeutics Inc. - - -
iShares Core DAX® 1.804% -0.748% 13.168%
iShares Nasdaq 100 -0.182% -3.412% 39.976%
iShares Nikkei 225® 0.413% -7.381% 18.776%
iShares S&P 500 0.664% -1.941% 28.141%

Comments by WatchMen for this prediction

In the thread Rubius Therapeutics Inc. diskutieren

Sell Rubius Therapeutics Inc.

In the thread Trading Rubius Therapeutics Inc.
Prediction Sell
Perf. (%) -98.17%
Target price
Change
Ends at 26.12.22

Die von WatchMen gewählte maximale Laufzeit wurde überschritten